User profiles for Jennifer X. Ji
Jennifer X. JiUniversity of British Columbia Verified email at alumni.ubc.ca Cited by 558 |
SWI/SNF complex mutations in gynecologic cancers: molecular mechanisms and models
The SWI/SNF (mating type SWItch/Sucrose NonFermentable) chromatin remodeling
complexes interact with histones and transcription factors to modulate chromatin structure and …
complexes interact with histones and transcription factors to modulate chromatin structure and …
Clear cell carcinomas of the ovary and kidney: clarity through genomics
JX Ji, YK Wang, DR Cochrane… - The Journal of …, 2018 - Wiley Online Library
Clear cell ovarian carcinoma (CCOC) and clear cell renal cell carcinoma (ccRCC) both
feature clear cytoplasm, owing to the accumulation of cytoplasmic glycogen. Genomic studies …
feature clear cytoplasm, owing to the accumulation of cytoplasmic glycogen. Genomic studies …
Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous …
YA Liu, JX Ji, N Almadani, RI Crawford… - …, 2021 - Wiley Online Library
Aims Differentiated vulvar intraepithelial neoplasia (dVIN), the precursor lesion to human
papillomavirus‐independent vulvar squamous cell carcinoma (VSCC), can be difficult to …
papillomavirus‐independent vulvar squamous cell carcinoma (VSCC), can be difficult to …
The proteome of clear cell ovarian carcinoma
Clear cell ovarian carcinoma (CCOC) is the second most common subtype of epithelial
ovarian carcinoma. Late‐stage CCOC is not responsive to gold‐standard chemotherapy and …
ovarian carcinoma. Late‐stage CCOC is not responsive to gold‐standard chemotherapy and …
Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase–deficient ovarian cancer, including small-cell carcinoma of the ovary …
JX Ji, DR Cochrane, B Tessier-Cloutier, SY Chen… - Clinical Cancer …, 2020 - AACR
Purpose: Many rare ovarian cancer subtypes, such as small-cell carcinoma of the ovary,
hypercalcemic type (SCCOHT), have poor prognosis due to their aggressive nature and …
hypercalcemic type (SCCOHT), have poor prognosis due to their aggressive nature and …
[HTML][HTML] The Canadian clinician-scientist training program must be reinstated
Clinical investigators within the Canadian and international communities were shocked when
the Canadian Institutes of Health Research (CIHR) announced that their funding for the MD…
the Canadian Institutes of Health Research (CIHR) announced that their funding for the MD…
Napsin-A and AMACR are superior to HNF-1β in distinguishing between mesonephric carcinomas and clear cell carcinomas of the gynecologic tract
Mesonephric carcinoma is a rare gynecologic neoplasm commonly mistaken for clear cell
carcinoma, because of their overlapping morphologic features. Both tumors are negative for …
carcinoma, because of their overlapping morphologic features. Both tumors are negative for …
Characteristics and outcomes of Canadian MD/PhD program graduates: a cross-sectional survey
Background: Combined MD/PhD programs provide a structured path for physician-scientist
training, but assessment of their success within Canada is limited by a lack of quantitative …
training, but assessment of their success within Canada is limited by a lack of quantitative …
[HTML][HTML] Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay
Conventional cytotoxic therapies for synovial sarcoma provide limited benefit. Drugs specifically
targeting the product of its driver translocation are currently unavailable, in part because …
targeting the product of its driver translocation are currently unavailable, in part because …
Use of immunohistochemical markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to distinguish endometrial clear cell carcinoma from its morphologic mimics including …
JX Ji, DR Cochrane, B Tessier-Cloutier… - International Journal …, 2020 - journals.lww.com
The diagnosis of clear cell (CC) carcinoma of the endometrium can be challenging, especially
when endometrioid (EC) and serous (SC) endometrial cancers exhibit nonspecific clear …
when endometrioid (EC) and serous (SC) endometrial cancers exhibit nonspecific clear …